EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Ketamine use for severe depression in Low resource settings – A case report

Frances Adiukwu, Best Akio, Chigozie Uwandu, Avwarute Ochei, Olufisayo Adesokun, Chimenum Wodu, Ibiye George, Precious Anuonyeh.

Nigerian Journal of Psychiatry · 2025 · 23 (1) · 56

DOI: 10.5455/njp.252547 ↗
AbstractBibliografische Angaben

Abstract

Background: Depression is a chronic mental disorder and has remained a leading cause of disease burden. The lifetime prevalence in Nigeria is estimated to range from 3.1% to 5.2%. However, higher prevalence rates have been documented in more recent studies. Aim: This case report and literature review is to bring to light the need for newer medications/interventions in the treatment of depression in low-resource countries such as Nigeria. Setting: This research was conducted at the University of Port Harcourt Teaching Hospital, Rivers State, Nigeria. Method: The managing team developed a protocol for the trial of ketamine infusion in the management of treatment-resistant depression (TRD) and depression with suicidality. Written consent was obtained before the Ketamine infusion therapy. Results: Patient was assessed using the Hamilton depression rating scale, which was significantly high before commencement of ketamine infusion at a value of 22/52, indicative of severe form, and progressively reduced to 13/52 after receiving the third dose of ketamine infusion therapy. Conclusion: Although being an instance case of a single trial of Ketamine infusion therapy, the authors report that the off-label use of Ketamine for the treatment of TRD in low-resource settings is feasible. Contribution: This case report would add to the evidence that off-label use of ketamine in the management of TRD is possible.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →